<DOC>
	<DOC>NCT00482079</DOC>
	<brief_summary>A dose-ranging study of MK0431 in patients with type 2 diabetes who have inadequate control of their blood sugar.</brief_summary>
	<brief_title>A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Age 21 to 70, You are a man or nonpregnant woman Have a history of type I diabetes You are on a weight loss program with ongoing weight loss or taking weight loss medications You have a history of minor surgery You have received investigational drugs within 8 weeks of study start You have hepatitis B or C</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>